Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amino Up Chemical Co.
Men on "watchful waiting" eligible for soy-mushroom extract trial
June 26th, 2004
Men who are on active surveillance or "watchful waiting" for prostate cancer may be eligible to enroll in a University of California (UC) Davis Cancer Center clinical trial of genistein concentrated polysaccharide, or GCP, a food extract derived from soybeans and shiitake mushrooms. The new study builds on a preliminary trial, completed last year, that found GCP reduced levels of prostate-specific antigen in a small group of "watchful waiting" patients. Watchful waiting is recommended for some prostate cancers that cause no symptoms, are expected to grow very slowly, and are small and contained within one area of the prostate. Prostate-specific...
Source: Law & Health Weekly (2004-06-26)
|